Skip to content

Drug interactions

Crizotinib + Mitomycin

Severity: Minor

Crizotinib and Mitomycin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Crizotinib may inhibit P-glycoprotein and theoretically increase mitomycin exposure. Mitomycin's toxicities include myelosuppression and hemolytic uremic syndrome, but the clinical relevance of this interaction is unproven.

What this interaction means in plain words

Crizotinib and Mitomycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Crizotinib belongs to Oncology; Mitomycin belongs to Oncology.

Evidence level: Low

Why it happens

Possible inhibition of P-glycoprotein-mediated efflux of mitomycin by crizotinib.

What to do

Monitor blood counts and renal function as per standard mitomycin care.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Mitomycin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Mitomycin?

MediHelp rates the interaction as minor. Crizotinib and Mitomycin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Crizotinib may inhibit P-glycoprotein and theoretically increase mitomycin exposure. Mitomycin's toxicities include myelosuppression and hemolytic uremic syndrome, but the clinical relevance of this interaction is unproven.

How serious is the interaction between Crizotinib and Mitomycin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and renal function as per standard mitomycin care.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in